# The Effect of Intrathecal Magnesium Sulfate on Shivering

> **NCT05427149** · NA · COMPLETED · sponsor: **Yuzuncu Yil University** · enrollment: 120 (actual)

## Conditions studied

- Magnesium Sulfate Causing Adverse Effects in Therapeutic Use
- Postoperative Shivering
- Cesarean Section Complications

## Interventions

- **DRUG:** 25 mg MgSO4 (Magnezyum Sulfat %15, Biofarma, Istanbul, Turkey)

## Key facts

- **NCT ID:** NCT05427149
- **Lead sponsor:** Yuzuncu Yil University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-10
- **Primary completion:** 2022-06-30
- **Final completion:** 2022-08-30
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2022-09-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05427149

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05427149, "The Effect of Intrathecal Magnesium Sulfate on Shivering". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05427149. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*